Skip to main content
. 2019 May 20;9(2):2045894019847643. doi: 10.1177/2045894019847643

Table 2.

Treatment of PH.

Treatment of PH n (%)
Sildenafil 4 (14.8)
Sildenafil and warfarin 2 (7.4 )
Sildenafil and bosentan 2 (7.4)
Sildenafil, bosentan, and warfarin 1 (3.7)
Sildenafil, bosentan, iloprost, and warfarin 2 (7.4)
Sildenafil, bosentan, surgery, and pulmonary rehabilitation 1 (3.7)
Bosentan 3 (11.1)
Bosentan and continuous positive pressure in airway (CPAP) 1 (3.7)
CPAP 1 (3.7)
Riociguat and warfarin 1 (3.7)
Apixaban 1 (3.7)
Surgery correction of congenital heart diseases 2 (7.4)
Oxygen 1 (3.7)
No treatment is registered 5 (18.5)
Total 27 (100)